{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:51:35Z","timestamp":1785415895831,"version":"3.56.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":2750,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jpain.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T08:45:07Z","timestamp":1450341907000},"page":"359-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes"],"prefix":"10.1016","volume":"17","author":[{"given":"Ryan B.","family":"Griggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee R.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braxton G.","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley K.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.","volume":"34","author":"Abbott","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1167\/iovs.03-0573","article-title":"Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins","volume":"44","author":"Ahmed","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jpain.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diacare.23.11.1605","article-title":"Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group","volume":"23","author":"Aronoff","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jpain.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/db07-1737","article-title":"Distal degenerative sensory neuropathy in a long-term type 2 diabetes rat model","volume":"57","author":"Brussee","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib7","first-page":"2015","article-title":"Characterisation of pain responses in the high fat diet\/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments","volume":"752481","author":"Byrne","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd2476","article-title":"Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials","volume":"8","author":"Calcutt","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jpain.2015.11.006_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00125-004-1354-2","article-title":"Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor","volume":"47","author":"Calcutt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.jpain.2015.11.006_bib10","first-page":"2009","article-title":"MBX-102\/JNJ39659100, a novel non-TZD selective partial PPAR-gamma agonist lowers triglyceride independently of PPAR-alpha activation","volume":"706852","author":"Chandalia","year":"2009","journal-title":"PPAR Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jpain.2008.02.002","article-title":"Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats","volume":"9","author":"Churi","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0705103","article-title":"Identification of MEK1 as a novel target for the treatment of neuropathic pain","volume":"138","author":"Ciruela","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2015.11.006_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3181\/00379727-173-41611","article-title":"The diabetic Zucker fatty rat","volume":"173","author":"Clark","year":"1983","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpain.2009.09.008","article-title":"A novel method to quantify histochemical changes throughout the mediolateral axis of the substantia gelatinosa after spared nerve injury: Characterization with TRPV1 and substance P","volume":"11","author":"Corder","year":"2010","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib15","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/en.2008-1757","article-title":"Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db\/db mice","volume":"150","author":"Dasu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpain.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/glia.22349","article-title":"Neuron\u2013astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes","volume":"60","author":"Dauch","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.jpain.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc05-2228","article-title":"The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes","volume":"29","author":"Davies","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(02)03828-3","article-title":"Mechanical hyperalgesia in rat models of systemic and local hyperglycemia","volume":"960","author":"Dobretsov","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-0270(01)00410-1","article-title":"Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution","volume":"110","author":"Dobretsov","year":"2001","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jpain.2015.11.006_bib20","unstructured":"Donahue RR, Adkins BG, Harte SE, Studer-Rabeler KE, Taylor BK: Gabapentin reduces motivational attributes of noxious mechanical stimuli after spared nerve injury. Society for Neuroscience Annual Meeting Abstracts 42:575.515, 2012"},{"key":"10.1016\/j.jpain.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1210\/en.2009-1342","article-title":"New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}","volume":"151","author":"Drel","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpain.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/152091503763816481","article-title":"Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease","volume":"5","author":"Feinstein","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jpain.2015.11.006_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2005.03.033","article-title":"Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?","volume":"70","author":"Feinstein","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jpain.2015.11.006_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1742-2094-9-180","article-title":"The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain","volume":"9","author":"Feldman","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jpain.2015.11.006_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2013.04.009","article-title":"Increases in inflammatory mediators in DRG implicate in the pathogenesis of painful neuropathy in Type 2 diabetes","volume":"63","author":"Galloway","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jpain.2015.11.006_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1876386300902010011","article-title":"c-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?","volume":"2","author":"Gao","year":"2009","journal-title":"Open Pain J"},{"key":"10.1016\/j.jpain.2015.11.006_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1471-4159.2010.06946.x","article-title":"Light touch induces ERK activation in superficial dorsal horn neurons after inflammation: Involvement of spinal astrocytes and JNK signaling in touch-evoked central sensitization and mechanical allodynia","volume":"115","author":"Gao","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpain.2015.11.006_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bmcl.2009.12.088","article-title":"Structure-based design of a thiazolidinedione which targets the mitochondrial protein mitoNEET","volume":"20","author":"Geldenhuys","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpain.2015.11.006_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/me.2008-0473","article-title":"MBX-102\/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence\u00a0of weight gain and edema","volume":"23","author":"Gregoire","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jpain.2015.11.006_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.j.pain.0000460333.79127.be","article-title":"Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARgamma mechanisms","volume":"156","author":"Griggs","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbrc.2012.08.039","article-title":"Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization","volume":"426","author":"Hasegawa-Moriyama","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpain.2015.11.006_bib32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpain.2012.03.011","article-title":"Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury","volume":"13","author":"He","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0034-1367023","article-title":"A new paradigm to understand and treat diabetic neuropathy","volume":"122","author":"Hidmark","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib34","doi-asserted-by":"crossref","first-page":"e0117516","DOI":"10.1371\/journal.pone.0117516","article-title":"Geraniol, alone and in combination with pioglitazone, ameliorates fructose-induced metabolic syndrome in rats via the modulation of both inflammatory and oxidative stress status","volume":"10","author":"Ibrahim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2015.11.006_bib35","doi-asserted-by":"crossref","first-page":"e0116625","DOI":"10.1371\/journal.pone.0116625","article-title":"Chronic ingestion of advanced glycation end products induces degenerative spinal changes and hypertrophy in aging pre-diabetic mice","volume":"10","author":"Illien-Junger","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2015.11.006_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0304-3959(98)00017-7","article-title":"The cold plate as a test of nociceptive behaviors: Description and application to the study of chronic neuropathic and inflammatory pain models","volume":"75","author":"Jasmin","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib37","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/16040","article-title":"Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity","volume":"2","author":"Ji","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpain.2015.11.006_bib38","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/jpi.12089","article-title":"Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats","volume":"55","author":"Jim\u00e9nez-Aranda","year":"2013","journal-title":"J Pineal Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/dmrr.541","article-title":"Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes","volume":"21","author":"Kamiya","year":"2005","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jpain.2015.11.006_bib40","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front Biosci"},{"key":"10.1016\/j.jpain.2015.11.006_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0034-1371818","article-title":"Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes","volume":"122","author":"Kender","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib42","doi-asserted-by":"crossref","first-page":"31052","DOI":"10.1074\/jbc.M109.052969","article-title":"Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors","volume":"284","author":"Kim","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2015.11.006_bib43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nn.2407","article-title":"Unmasking the tonic-aversive state in neuropathic pain","volume":"12","author":"King","year":"2009","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpain.2015.11.006_bib44","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2337\/db08-1763","article-title":"Selective T-type calcium channel blockade alleviates hyperalgesia in ob\/ob mice","volume":"58","author":"Latham","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/1545968312445637","article-title":"Herpes simplex virus vector\u2013mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury","volume":"26","author":"Lau","year":"2012","journal-title":"Neurorehabil Neural Repair"},{"key":"10.1016\/j.jpain.2015.11.006_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2015.04.026","article-title":"Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARgamma agonist in\u00a0vitro and in MPTP-treated mice","volume":"302","author":"Lecca","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2015.11.006_bib47","first-page":"140","article-title":"Animal models of diabetes-induced neuropathic pain","volume":"20","author":"Lee-Kubli","year":"2014","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.jpain.2015.11.006_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/dc10-1068","article-title":"Risk of bladder cancer among diabetic patients treated with pioglitazone: Interim report of a longitudinal cohort study","volume":"34","author":"Lewis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2006.01.012","article-title":"Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats","volume":"22","author":"Li","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jpain.2015.11.006_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0006-8993(99)02070-3","article-title":"NMDA and AMPA glutamate receptor subtypes in the thoracic spinal cord in lean and obese-diabetic ob\/ob mice","volume":"849","author":"Li","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib51","doi-asserted-by":"crossref","first-page":"e112066","DOI":"10.1371\/journal.pone.0112066","article-title":"Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker Fatty rats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2015.11.006_bib52","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.brainres.2010.10.044","article-title":"Spinal astrocytic activation contributes to mechanical allodynia in a mouse model of type 2 diabetes","volume":"1368","author":"Liao","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13814788.2014.887674","article-title":"Chronic pain in type 2 diabetic patients: A cross-sectional study in primary care setting","volume":"20","author":"Liberman","year":"2014","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/j.jpain.2015.11.006_bib54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejphar.2015.06.010","article-title":"Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin","volume":"764","author":"Ma","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2015.11.006_bib55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1254\/jphs.08207FP","article-title":"Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury","volume":"108","author":"Maeda","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jpain.2015.11.006_bib56","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jpain.2015.11.006_bib57","doi-asserted-by":"crossref","first-page":"e100701","DOI":"10.1371\/journal.pone.0100701","article-title":"The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model","volume":"9","author":"Mao-Ying","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2015.11.006_bib58","first-page":"2008","article-title":"Potential therapeutic targets for PPARgamma after spinal cord injury","volume":"517162","author":"McTigue","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib59","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMcp022282","article-title":"Painful sensory neuropathy","volume":"348","author":"Mendell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib60","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1463-1326.2006.00619.x","article-title":"Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor \u03b3 agonist, FK614, ameliorates insulin resistance in Zucker fatty rats","volume":"9","author":"Minoura","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jpain.2015.11.006_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2015.11.006_bib62","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2009.10.008","article-title":"Activation of peroxisome proliferator-activated receptor [gamma] in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema","volume":"58","author":"Morgenweck","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2015.11.006_bib63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2013.01.020","article-title":"PPARgamma activation blocks development and reduces established neuropathic pain in rats","volume":"70","author":"Morgenweck","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jpain.2015.11.006_bib64","unstructured":"Morrow TJ, Harte SE: Mechanical conflict system (MCS): A novel operant method for assessing acute and chronic nociception. Winter Conference on Brain Research Abstracts 43:138, 2010"},{"key":"10.1016\/j.jpain.2015.11.006_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2337\/diabetes.50.1.131","article-title":"Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats","volume":"50","author":"Munoz","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib66","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.nurt.2009.07.004","article-title":"Diabetic painful and insensate neuropathy: Pathogenesis and potential treatments","volume":"6","author":"Obrosova","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jpain.2015.11.006_bib67","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.2337\/diabetes.54.12.3435","article-title":"Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited","volume":"54","author":"Obrosova","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib68","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.freeradbiomed.2007.09.013","article-title":"PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy","volume":"44","author":"Obrosova","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3959(02)00313-5","article-title":"Pain phenomena and possible mechanisms in patients with painful polyneuropathy","volume":"101","author":"Otto","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib70","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1526-4637.2011.01067.x","article-title":"Longitudinal study of painful diabetic neuropathy in the Zucker diabetic fatty rat model of type 2 diabetes: impaired basal G-protein activity appears to underpin marked morphine hyposensitivity at 6 months","volume":"12","author":"Otto","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib71","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1124\/jpet.106.113472","article-title":"Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss,\u00a0neuropathic pain, and inflammation after spinal cord injury in adult rats","volume":"320","author":"Park","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2015.11.006_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1463-1326.1999.00020.x","article-title":"Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study","volume":"1","author":"Patel","year":"1999","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jpain.2015.11.006_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1056-8727(99)00034-3","article-title":"Thermal, but not mechanical, nociceptive behavior is altered in the Zucker diabetic fatty rat and is independent of glycemic status","volume":"13","author":"Piercy","year":"1999","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jpain.2015.11.006_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/JPR.S21751","article-title":"High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy","volume":"4","author":"Purwata","year":"2011","journal-title":"J Pain Res"},{"key":"10.1016\/j.jpain.2015.11.006_bib75","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2337\/db06-1269","article-title":"Pathogenesis of spinally mediated hyperalgesia in diabetes","volume":"56","author":"Ramos","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib76","first-page":"233","article-title":"Anti-inflammatory effects of xylopropamine","volume":"113","author":"Randall","year":"1957","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jpain.2015.11.006_bib77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.brainresbull.2012.03.002","article-title":"High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes","volume":"88","author":"Ren","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jpain.2015.11.006_bib78","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0031-9384(86)90156-3","article-title":"Nociception and opioid-induced analgesia in lean (Fa\/-) and obese (fa\/fa) Zucker rats","volume":"38","author":"Roane","year":"1986","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jpain.2015.11.006_bib79","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neulet.2008.08.087","article-title":"Pressure pain precedes development of type 2 disease in Zucker rat model of diabetes","volume":"445","author":"Romanovsky","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jpain.2015.11.006_bib80","first-page":"2011","article-title":"Electroacupuncture Zusanli (ST36) on release of nitric oxide in the gracile nucleus and improvement of sensory neuropathies in Zucker diabetic fatty rats","volume":"134545","author":"Rong","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib81","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/dc10-1546","article-title":"A1C versus glucose testing: A comparison","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib82","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/ALN.0000000000000892","article-title":"Resolution of inflammation by resolvin D1 is essential for peroxisome proliferator-activated receptor-\u03b3-mediated analgesia during postincisional pain development in type 2 diabetes","volume":"123","author":"Saito","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2015.11.006_bib83","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diabres.2007.01.016","article-title":"Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat","volume":"77","author":"Saitoh","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jpain.2015.11.006_bib84","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.expneurol.2010.10.003","article-title":"Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury","volume":"227","author":"Sauerbeck","year":"2011","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2015.11.006_bib85","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/jnen\/63.5.450","article-title":"Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy","volume":"63","author":"Schmidt","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jpain.2015.11.006_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0002-9440(10)63626-7","article-title":"Analysis of the Zucker diabetic fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin\/IGF-I in diabetic autonomic neuropathy","volume":"163","author":"Schmidt","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jpain.2015.11.006_bib87","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neuroscience.2015.02.003","article-title":"Electrophysiological characterization of spinal neurons in different models of diabetes type 1 and type 2- induced neuropathy in rats","volume":"291","author":"Schuelert","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jpain.2015.11.006_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1185\/03007995.2010.537589","article-title":"Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial","volume":"27","author":"Schwartz","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpain.2015.11.006_bib89","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/db11-1524","article-title":"Metanx alleviates multiple manifestations of peripheral neuropathy and increases intraepidermal nerve fiber density in Zucker diabetic fatty rats","volume":"61","author":"Shevalye","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jpain.2015.11.006_bib90","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2165\/11588940-000000000-00000","article-title":"Pharmacological treatment of diabetic neuropathic pain","volume":"71","author":"Smith","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jpain.2015.11.006_bib91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(94)90130-9","article-title":"Conditioned place preference paradigm: A novel approach for analgesic drug assessment against chronic pain","volume":"58","author":"Sufka","year":"1994","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib92","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/dmrr.903","article-title":"Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia","volume":"24","author":"Sugimoto","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jpain.2015.11.006_bib93","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.2337\/dc13-0788","article-title":"Small- and large-fiber neuropathy after 40 years of type 1 diabetes: Associations with glycemic control and advanced protein glycation: The Oslo Study","volume":"36","author":"Sveen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jpain.2015.11.006_bib94","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cne.902310106","article-title":"The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord","volume":"231","author":"Swett","year":"1985","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jpain.2015.11.006_bib95","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1213\/ANE.0b013e31821b220c","article-title":"The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development","volume":"113","author":"Takahashi","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jpain.2015.11.006_bib96","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1124\/jpet.114.220673","article-title":"A novel MitoNEET ligand, TT01001, improves diabetes and ameliorates mitochondrial function in db\/db mice","volume":"352","author":"Takahashi","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2015.11.006_bib97","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/ALN.0000000000000893","article-title":"Resolvin D1: A new path to unleash the analgesic potential of peroxisome proliferator-activated receptor-gamma for postoperative pain in patients with diabetes","volume":"123","author":"Taylor","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpain.2015.11.006_bib98","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrn2294","article-title":"Glucose neurotoxicity","volume":"9","author":"Tomlinson","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jpain.2015.11.006_bib99","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/01.wnl.0000265062.92340.a5","article-title":"Differential expression of cytokines in painful and painless neuropathies","volume":"69","author":"Uceyler","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpain.2015.11.006_bib100","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabet.2008.11.004","article-title":"Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics","volume":"35","author":"Van Acker","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jpain.2015.11.006_bib101","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.pbb.2012.05.008","article-title":"Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes","volume":"102","author":"Vera","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jpain.2015.11.006_bib102","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: Cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jpain.2015.11.006_bib103","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jpain.2014.05.008","article-title":"Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy","volume":"15","author":"Wagner","year":"2014","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib104","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2014.01.030","article-title":"Activation of PPAR\u03b3 attenuates LPS-induced acute lung injury by inhibition of HMGB1-RAGE levels","volume":"726","author":"Wang","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jpain.2015.11.006_bib105","doi-asserted-by":"crossref","first-page":"e0116851","DOI":"10.1371\/journal.pone.0116851","article-title":"Beneficial effects of canagliflozin in combination with pioglitazone on insulin sensitivity in rodent models of obese type 2 diabetes","volume":"10","author":"Watanabe","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2015.11.006_bib106","first-page":"254","article-title":"Pressure pain perception at the injured foot: the impact of diabetic neuropathy","volume":"12","author":"Wienemann","year":"2012","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jpain.2015.11.006_bib107","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: Implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib108","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/joim.12293","article-title":"Comparison of the effects on glycaemic control and \u03b2-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: A multicentre randomized parallel-group trial (the CONFIDENCE study)","volume":"277","author":"Xu","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.jpain.2015.11.006_bib109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12264-013-1387-y","article-title":"Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes","volume":"30","author":"Xu","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.jpain.2015.11.006_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1471-4159.2007.05050.x","article-title":"Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-\u03b3-ligand, in insulin-deficient diabetic rats","volume":"104","author":"Yamagishi","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jpain.2015.11.006_bib111","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2174\/1389450111314070003","article-title":"Targeting PPAR isoforms following CNS injury","volume":"14","author":"Yonutas","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jpain.2015.11.006_bib112","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pain.2004.12.022","article-title":"ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model","volume":"114","author":"Zhuang","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.11.006_bib113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/exnr.1996.0129","article-title":"Insulin-like growth factors reverse or arrest diabetic neuropathy: Effects on hyperalgesia and impaired nerve regeneration in rats","volume":"140","author":"Zhuang","year":"1996","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jpain.2015.11.006_bib114","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-3565(24)37002-8","article-title":"Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates diabetic neuropathy","volume":"283","author":"Zhuang","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpain.2015.11.006_bib115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015009761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015009761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T20:45:28Z","timestamp":1748724328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590015009761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1526590015009761"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2015.11.006","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}